Dr. Thomas J. Hudson is the Sr. VP of R&D and Chief Scientific Officer at Abbvie Inc.
Dr Hudson is 59, he's been the Sr. VP of R&D and Chief Scientific Officer of Abbvie Inc since . There are 11 older and 20 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.
Thomas's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over 324,915,370$ worth of Abbvie Inc stock and bought 214,015 units worth 14,446,494$ . The most active insiders traders include Richard A Gonzalez、Frederick H Waddell、Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of 7,529,855$. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth 12,403,580$.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: